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Issues relating to the effects of microgravity (l.tG) on pituitary cell
function require an understanding of how these cells are thought to be
controlled and function both in vivo and in vitro. Our experimental designs
for spaceflight research have been driven by current ground based research.
Ground based research. The mammalian pituitary is a small, well protected
gland that is vitally important for the control of proper body function. A
rigorous understanding of that control is hindered by heterogeneities, both
cellular and molecular, of different hormone subsystems that we believe exist
within the pituitary gland. The fact that there are disproportionate numbers
of growth hormone (GH)- and prolactin (PRL)-producing cells must certainly
reflect the importance of these two protein hormones in body metabolism.
Results of intensive research now make it quite clear that these hormones are
multifunctional. In the case of GH, for example, the hormone is a) involved in
metabolism of fat, carbohydrate and protein and b) has receptors for GH that
can be found on numerous tissues such as bone, muscle, liver and cells of the
immune system. In light of these diverse biological activities, the idea that a
single GH assay might not detect all of them is not surprising. Thus, hormone
assays based on immunological techniques, while being easy and relatively
inexpensive, may not always yield correct potency estimates (Ellis and
Grindeland, 1974). Ongoing work in our laboratories unequivocally
demonstrate that GH cells are heterogeneous with regard to the biological
activity of the hormone they secrete (Grindeland, R. and W.C. Hymer.
Differential Release of Bioreactive to Immunoreactive Growth Hormone from
Separated Somatotrophs. Proc. Soc. Exp. Bio. Med. Manuscript submitted.).
In addition to heterogeneity of GH activities and GH cells, heterogeneities
also exist within the GH molecules themselves. For example, alternative
splicing of the GH mRNA results in two variants that may have different
biological activites. Furthermore, post-translational modifications such as
phosporylation, proteolytic cleavage, glycosylation and disulfide aggregation
are known to occur within the gland (Lewis, 1984). Apart from one recent
abstract (Farrington and Hymer, 1988) a positive correlation between these
cellular and molecular heterogeneities has yet to be made.
While the foregoing comments relate to GH once released from the cell, it is
important to know that sensitive techniques are now available to study GH
cells themselves, For example, it is possible to 1) objectively categorize 30,000
cells by flow cytometry to determine percentages of GH cells in a suspension
(Hatfield, and Hymer, 1985); 2) obtain information concerning the cells
internal structure by laser flow cytometry (Hatfieid, and Hymer, 1986a;
Hatfield and Hymer, 1986b) 3) quantitatively measure measure hormone
release from single cells (Kendall and Hymer, 1987); 4) isolate GH cells and GH
cell subpopulations (Snyder et al, 1977); 5) maintain GH cells in culture in
either serum-containing or serum-free media (Grindeland et al, 1987) and
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finally 6) implant GH cells into the living animal using hollow fiber
technology (Hymer et al, 1981) to determine the effects of the secreted GH in
vivo.
Since the subject of this conference relates to I_G effects directly at the
cellular level, it is particularly important to understand the rationale and
ramifications underlying the hollow fiber procedure. In this technique
living cells (2x105) are injected (1.5 !11) into the lumen of a 10 mm XM-50 fiber
and sealed-in using wax on the fiber ends. The fibers are implanted into the
brains of hypophysectomized rats in such a way that the fiber courses
through the lateral ventricles and is bathed in cerebral spinal fluid. This fluid
is rich in a peptide (GRF) that can stimulate the encapsulated GH cells to
release hormone from the fiber into the recipient's bloodstream so that the
biological consequences of the hormone can be assessed by measurement of
the tibial epiphyseal plate width some 10 days post-implantation.
Results of pituitary_ cell spaceflight research. Three experiments have
been done to date; 1) STS-8 (1983); 2) SL-3 (1985) and 3) Cosmos 1887 (1987). In
two cases pituitary glands, obtained from male rats that had flown in IxG for 7
days (SL-3) or 13 days (Cosmos 1887), were used to prepare cells for subsequent
study on Earth. In the other experiment, dispersed cells were maintained in a
closed tube containing culture medium and serum at 37 ° C in a middeck locker.
On return, the cells were recovered and cultured in fresh serum-containing
medium for 6 days to determine what effect exposure to _tG might have on the
ability of the cell to release GH.
The results of these 3 experiments are summarized in Table 1. Details of
each experiment can be found in (Hymer et al, 1987; STS-8), (Grindeland et al,
1987; SL-3) and (Hymer WC, Grindeland R, Krasnov I, Sawchenko P, Victorov I,
Vale, W, Motter K and Vasques M. Changes in Pituitary growth hormone cells
prepared from rats flown on Cosmos 1887. Manuscript submitted). Clearly,
exposure to IxG subsequently affected GH release fom the pituitary cell. Since
most of our data come from rats that have "flown" in space, it is tempting (at
first glance) to attribute the results to physiological effects at the
organ/systemic level; for example, changes in fluid shifts, microcirculation,
non-specific stress and the like. Closer inspection of our results, however,
support the counter hypothesis that exposure to the unique environment of
space affects secretory processes directly at the level of the pituitary cell. The
arguments are:
• implantation of cells from flight rats into hypophysectomized rats, under
conditions where flight cells could be maximally stimulated to release GH,
clearly did not. This suggests a "secretory defect" within the flight cell that
was maintained on subsequent testing in vivo.
• culture of cells from flight rats consistently showed partial shutdown of
GH release.
• continued culture of cells that "flew" in space also showed shutdown of GH
release on Earth.
What intracellular mechanisms could account for the effect? Some of the
more obvious targets are a) the microtubular system; b) the GH packing system
(golgi/secretory granu!e) and c) plasma membrane receptor defects. Since
the fluorescence staining intensity of the GH cell is increased (Table 1), we
currently favor the hypothesis that hormone packaging is a likely target.
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However, microtubule "motors" drive the granules out of the cell and receptor
function is likely to be mechanically coupled to these motors. Future
experiments will test these various possibilities.
Since GH controls the function of other systems(bone, muscle, immune)
which are themselvesaffected by IxG, our researchis relevant to the issue of
long-term manned spaceflight.
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TABLE 1
Summary of results of three spaceflight experiments concerned with effects of _G on
pituitary growth hormone cell function.
QUESTION
1. Is GH release
affected _?
(immunoassay)
METHOD FLIGHT
Cell Culture STS-8
" SL-3
" 1887
RESULTS
Yes. Reduced 20 fold
Yes. Reduced by ~ 50%.
Yes. Reduced by ~ 30%.
2. Is GH release
affected in vitro?
(bioassay)
HPLC of
culture
media-3T3
cell bioassay
Tibial assay
of culture
media
SL-3
1887
Yes. Activity of high molecular
weight hormone reduced.
Yes. Activity reduced by ~ 50%
3. Is GH release
affected in vivo?
(bioassay)
Hollow fiber
Implantation
SL-3
1887
Yes. Reduced by ~ 50%.
Yes. Reduced by ~ 50%.
4. Is the percentage
of GH cells affected?
Laser flow
immuno-
fluorescence
SL-3
1887
NO.
NO.
5. Is the size of the
GH cell affected?
Laser light
scatter
SL-3
1887
NOo
NO.
6. Is the GH
fluorescence
staining intensity
affected?
Laser flow
immuno-
fluorescence
SL-3
1887
Yes. Increased about
16%/cell
Yes. Intensity doubled/cell
7. Are the variant
forms of GH
affected?
Western
blotting
SL-3 NO.
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